Related Experiment Videos
Lung transplantation for alpha 1-antitrypsin deficiency emphysema
1Lung Transplant Program, Washington University-Barnes Hospital, St. Louis, USA.
Chest
|December 1, 1996
Summary
Lung transplantation offers excellent functional outcomes for emphysema patients with alpha 1-antitrypsin deficiency. Further research is needed to clarify the role of alpha 1-antitrypsin replacement therapy post-transplant.
Area of Science:
- Pulmonology
- Transplant Surgery
- Genetics
Background:
- Alpha 1-antitrypsin deficiency is a genetic cause of emphysema.
- End-stage emphysema necessitates lung transplantation for survival.
- Lung transplantation is a viable treatment option for select patients.
Purpose of the Study:
- To evaluate the efficacy of lung transplantation in alpha 1-antitrypsin deficiency-related emphysema.
- To assess functional and survival outcomes after lung transplantation.
- To investigate the necessity of alpha 1-antitrypsin replacement therapy post-transplant.
Main Methods:
- Review of patient data following single or bilateral lung transplantation.
- Analysis of functional recovery and medium-term survival rates.
- Assessment of the impact of alpha 1-antitrypsin replacement therapy.
Main Results:
- Excellent functional results observed post-transplantation.
- Good medium-term survival rates reported.
- The role of alpha 1-antitrypsin replacement therapy remains unclear.
Conclusions:
- Lung transplantation is effective for emphysema due to alpha 1-antitrypsin deficiency.
- Further studies are required to determine the benefit of alpha 1-antitrypsin replacement therapy after lung transplantation.